A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.
- DOI
- 10.1038/s41587-026-03238-6
- Published
- 2026 Aug 19
- Container
- Nature biotechnology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41587-026-03238-6,
title = {A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.},
author = {Erasmus MF and Bedinger D and Hopkins E and Ferguson G and Strickler J and Graff CP and Summers SR and Capehart SL and Slocum JD and Richardson C and Kumar S and Sun Z and Shang Y and Zhang J and Gu M and Yi L and Wellner A and Zheng S and Lu W and Sormanni P and Greenig M and Zhang H and Mann BT and Baghbanzadeh M and Rahnavard A and Moore GL and Sun H and Ding Y and Nisthal A and Kanodia J and Bernett MJ and Pélissier A and Shao Y and Rodriguez Martinez M and Ramesh K and Nastri H and Evers A and Abdelatif A and Bordner AJ and Bordyuh M and Heo L and Kidd BA and Serhat Tetikol H and Wei S and Shin JE and Peckner R and Manley L and Lunge A and Devasurmutt Y and Guloglu B and Copoiu L and McGibbon M and Fernandez-Quintero ML and Mishra N and Callaghan SM and Swanson OM and Bader DLV and Ferguson JA and Raghavan SSR and Nemoz B and Maillie CA and Bowman C and Briney B and Ward AB and Marcatili P and Akbar R and He B and Wu F and Yao J and Hu B and Kucer M and Gibson KR and Somasundaram R and Hung LW and Kaszuba T and Fremont DH and Jeong H and Kurella VB and Malhotra S and Kumar S and Liu Y and Xu L and Misa J and John ANS and Vogt J and Dávila-Hernández FA and Xu D and Chungyoun M and Huggan ZD and Gray JJ and Parkinson J and Ko YS and Wang W and Geiger F and Ziegler JD and Haas N and Challacombe C and Qamar A and Singh A and Tang YC and An Z and Jiang X and Kim Y and Zhao X and Swanson E and Klattig J and Winkler K and Bataa T and Sandig V and Denzler L and Liu C and Brezski RJ and Spector L and Perea-Schmittle K and D'Angelo S and Ferrara F and Bradbury ARM},
year = {2026},
journal = {Nature biotechnology},
doi = {10.1038/s41587-026-03238-6},
url = {https://doi.org/10.1038/s41587-026-03238-6}
}RIS
TY - JOUR TI - A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability. AU - Erasmus MF AU - Bedinger D AU - Hopkins E AU - Ferguson G AU - Strickler J AU - Graff CP AU - Summers SR AU - Capehart SL AU - Slocum JD AU - Richardson C AU - Kumar S AU - Sun Z AU - Shang Y AU - Zhang J AU - Gu M AU - Yi L AU - Wellner A AU - Zheng S AU - Lu W AU - Sormanni P AU - Greenig M AU - Zhang H AU - Mann BT AU - Baghbanzadeh M AU - Rahnavard A AU - Moore GL AU - Sun H AU - Ding Y AU - Nisthal A AU - Kanodia J AU - Bernett MJ AU - Pélissier A AU - Shao Y AU - Rodriguez Martinez M AU - Ramesh K AU - Nastri H AU - Evers A AU - Abdelatif A AU - Bordner AJ AU - Bordyuh M AU - Heo L AU - Kidd BA AU - Serhat Tetikol H AU - Wei S AU - Shin JE AU - Peckner R AU - Manley L AU - Lunge A AU - Devasurmutt Y AU - Guloglu B AU - Copoiu L AU - McGibbon M AU - Fernandez-Quintero ML AU - Mishra N AU - Callaghan SM AU - Swanson OM AU - Bader DLV AU - Ferguson JA AU - Raghavan SSR AU - Nemoz B AU - Maillie CA AU - Bowman C AU - Briney B AU - Ward AB AU - Marcatili P AU - Akbar R AU - He B AU - Wu F AU - Yao J AU - Hu B AU - Kucer M AU - Gibson KR AU - Somasundaram R AU - Hung LW AU - Kaszuba T AU - Fremont DH AU - Jeong H AU - Kurella VB AU - Malhotra S AU - Kumar S AU - Liu Y AU - Xu L AU - Misa J AU - John ANS AU - Vogt J AU - Dávila-Hernández FA AU - Xu D AU - Chungyoun M AU - Huggan ZD AU - Gray JJ AU - Parkinson J AU - Ko YS AU - Wang W AU - Geiger F AU - Ziegler JD AU - Haas N AU - Challacombe C AU - Qamar A AU - Singh A AU - Tang YC AU - An Z AU - Jiang X AU - Kim Y AU - Zhao X AU - Swanson E AU - Klattig J AU - Winkler K AU - Bataa T AU - Sandig V AU - Denzler L AU - Liu C AU - Brezski RJ AU - Spector L AU - Perea-Schmittle K AU - D'Angelo S AU - Ferrara F AU - Bradbury ARM PY - 2026 JO - Nature biotechnology DO - 10.1038/s41587-026-03238-6 UR - https://doi.org/10.1038/s41587-026-03238-6 ER -
APA
MF, E., D, B., E, H., G, F., J, S., CP, G., SR, S., SL, C., JD, S., C, R., S, K., Z, S., Y, S., J, Z., M, G., L, Y., A, W., S, Z., W, L., P, S., M, G., H, Z., BT, M., M, B., A, R., GL, M., H, S., Y, D., A, N., J, K., MJ, B., A, P., Y, S., M, R. M., K, R., H, N., A, E., A, A., AJ, B., M, B., L, H., BA, K., H, S. T., S, W., JE, S., R, P., L, M., A, L., Y, D., B, G., L, C., M, M., ML, F., N, M., SM, C., OM, S., DLV, B., JA, F., SSR, R., B, N., CA, M., C, B., B, B., AB, W., P, M., R, A., B, H., F, W., J, Y., B, H., M, K., KR, G., R, S., LW, H., T, K., DH, F., H, J., VB, K., S, M., S, K., Y, L., L, X., J, M., ANS, J., J, V., FA, D., D, X., M, C., ZD, H., JJ, G., J, P., YS, K., W, W., F, G., JD, Z., N, H., C, C., A, Q., A, S., YC, T., Z, A., X, J., Y, K., X, Z., E, S., J, K., K, W., T, B., V, S., L, D., C, L., RJ, B., L, S., K, P., S, D., F, F., & ARM, B. (2026). A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.. Nature biotechnology. https://doi.org/10.1038/s41587-026-03238-6
Source records
- pubmed · retrieved 2026-09-26T03:56:57.485Z